On April 29, 2024, Pfizer Inc announced that it held its annual general meeting of shareholders on April 25, 2024, and declared voting results. Accordingly, a shareholder proposal from National Center for Public Policy Research, to Publish a Report on Corporate Contributions was not approved by the shareholders of the Company votes for approval 137,986,751; votes against 3,505,075,475; abstentions 59,125,487; broker non-votes 893,428,132.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.49 USD | +0.61% | +4.20% | +2.43% |
Jun. 04 | Pfizer: article on Lyme vaccine in The Lancet | CF |
Jun. 04 | Pfizer Partners with Abu Dhabi to Advance Research on Sickle Cell Disease | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.43% | 167B | |
+42.83% | 750B | |
+34.11% | 606B | |
-5.70% | 356B | |
+18.06% | 326B | |
+4.63% | 286B | |
+18.00% | 246B | |
+10.90% | 213B | |
-2.94% | 213B | |
+6.67% | 165B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Declaration of Voting Results by Pfizer Inc